Skip links

KYMBEE™ (deflazacort)

Full Name KYMBEE™ (deflazacort)
Drug deflazacort
Manufacturer Upsher-Smith
Route of Administration Oral
Site of Care Home
Approved Indication Treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older
Disease Duchenne Muscular Dystrophy (DMD)
Therapeutic Area Neurology
Enrollment Form Link Enrollment Form
Phone Number 847-849-1551
Fax Number 847-423-6222
Patient Resources Alex Rezcalla Foundation, Jett Foundation, Muscular Dystrophy Association, and Parent Project Muscular Dystrophy